Ron Squarer
Insider Reports History
- Location
- San Diego, CA
- Signature
- /s/ Nathan N. McConarty, attorney-in-fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Ron Squarer:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Travere Therapeutics, Inc. | Director | Common Stock | 35,375 | $648,423 | $18.33 | 15 May 2025 | Direct |
| ADC Therapeutics SA | Director | Common Shares | 93,627 | $335,184 | $3.58 | 13 Jun 2025 | Direct |
| Nuvalent, Inc. | Director | Class A Common Stock | 2,837 | $240,180 | $84.66 | 10 Dec 2025 | Direct |
| Deciphera Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | $0 | $10.58 | 11 Jun 2024 | Direct |
| Travere Therapeutics, Inc. | Director | Stock option (right to buy) | 19,500 | 15 May 2025 | Direct | ||
| Nuvalent, Inc. | Director | Stock Option (Right to Buy) | 4,418 | 10 Dec 2025 | Direct |